| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.79B | 2.74B | 2.77B | 2.59B | 2.43B | 1.95B |
| Gross Profit | 1.05B | 1.04B | 1.02B | 885.53M | 837.98M | 682.47M |
| EBITDA | 526.97M | 531.41M | 509.37M | 435.40M | 404.83M | 299.25M |
| Net Income | 242.84M | 264.84M | 205.28M | 223.75M | 235.11M | 157.41M |
Balance Sheet | ||||||
| Total Assets | 4.87B | 4.03B | 3.83B | 3.75B | 3.46B | 3.39B |
| Cash, Cash Equivalents and Short-Term Investments | 218.22M | 249.36M | 102.00M | 72.02M | 41.21M | 49.21M |
| Total Debt | 1.47B | 1.16B | 1.12B | 1.31B | 109.24M | 97.04M |
| Total Liabilities | 2.71B | 2.23B | 2.18B | 2.37B | 959.53M | 841.06M |
| Stockholders Equity | 2.12B | 1.77B | 1.61B | 1.35B | 2.46B | 2.50B |
Cash Flow | ||||||
| Free Cash Flow | 238.03M | 303.62M | 282.32M | 174.12M | 215.15M | 269.04M |
| Operating Cash Flow | 290.39M | 355.40M | 330.49M | 214.36M | 250.74M | 309.18M |
| Investing Cash Flow | -553.53M | -205.70M | -62.24M | -184.42M | -35.27M | -34.57M |
| Financing Cash Flow | 218.36M | 31.67M | -219.72M | 7.56M | -221.57M | -326.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $3.33B | 10.65 | 27.28% | 0.67% | 1.55% | 701.41% | |
78 Outperform | $15.79B | 37.48 | 25.43% | ― | 7.75% | 6.84% | |
78 Outperform | $13.03B | 17.54 | 26.06% | 0.85% | 15.71% | 29.60% | |
75 Outperform | $16.61B | 40.78 | 23.16% | 0.24% | 2.40% | 81.54% | |
72 Outperform | $2.63B | 24.89 | 11.31% | 1.27% | 7.43% | 148.83% | |
69 Neutral | $6.94B | 28.87 | 13.86% | 0.33% | 1.19% | -7.78% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
On December 4, 2025, ESAB Corporation announced the appointment of Dr. Sébastien Martin to its Board of Directors, effective January 1, 2026, increasing the board size to ten members. Dr. Martin, an Associate Professor at Kellogg School of Management, brings expertise in AI and operations management, which is expected to enhance ESAB’s strategic direction and operational efficiency. Concurrently, Patrick Allender announced his retirement from the board, effective after the 2026 annual meeting, marking the end of his significant contributions since ESAB’s independent listing in 2022.
On October 16, 2025, ESAB Corporation entered into an Amended and Restated Credit Agreement, which includes a $350 million senior term loan facility and a $1.05 billion senior revolving credit facility. This agreement replaces the company’s existing credit facilities and will be used for working capital and corporate purposes. The new facilities, maturing on October 16, 2030, offer flexible interest rate options and include covenants that limit the company’s ability to incur additional debt and require maintenance of certain financial ratios. This move is expected to streamline ESAB’s financial operations and potentially improve its leverage and interest coverage ratios.